Pasqal Plots Public Debut With Over $500M Quantum SPAC Raise

French quantum computing startup Pasqal is preparing to tap the public markets through a SPAC transaction that could bring in more than $500m in new capital and value the company at roughly 100 times its previous price tag. The move, outlined in recent regulatory filings, would put one of Europe’s flagship quantum players on a dramatically larger funding footing than most private rounds in the sector.

Pasqal builds quantum computing systems, a category of hardware designed to solve problems that are intractable for today’s classical machines. Quantum platforms are being developed for use cases such as optimisation, simulation and advanced cryptography, spanning industries from finance and logistics to energy and pharmaceuticals. The field is capital-intensive and still early in commercial adoption, which is why large, lumpy funding events like this SPAC are closely watched by founders and investors across deeptech.

The SPAC deal structure would channel more than half a billion dollars of fresh financing into Pasqal, subject to the usual public market closing conditions. That level of capital is unusual for a European quantum startup and would position the company to compete in a race that has so far been dominated by US and Asian players. Filings also point to a step-change in valuation: the transaction implies a market value roughly 100x higher than the company’s prior mark, signalling strong expectations for future growth.

Alongside the headline numbers, the documents highlight a set of risks tied to the company’s roots and backers, including references to potential “French state influence.” That language matters for founders working at the intersection of strategic technologies and national interests: it underlines how government support can be both a catalyst for scaling and a factor that public-market investors will scrutinise for governance or control concerns. For quantum startups, where state involvement is common via grants, procurement and strategic funds, these dynamics are increasingly part of the fundraising narrative.

For other founders in quantum and adjacent hard-science sectors, Pasqal’s planned listing is notable on several fronts. It shows that even in an environment where traditional IPO windows have been narrow, SPACs remain a viable path for capital-intensive deeptech companies that can articulate a long-term story. It also sends a signal on valuation: public investors are willing, at least on paper, to ascribe software-style multiples to hardware-heavy quantum bets, provided there is a credible roadmap to commercialisation.

What happens next will hinge on how public investors respond as the deal progresses. Redemption levels, final capital raised and early trading performance will be key signals for the wider market. If Pasqal closes near the indicated funding amount and sustains its implied valuation, it could reset expectations for late-stage financing in European quantum and encourage more companies to explore public routes earlier. If the deal is heavily adjusted or repriced, it will still offer a detailed case study on how much risk and state involvement public markets are comfortable underwriting in frontier technologies.

For now, the SPAC plans underscore a broader shift: quantum computing startups are starting to think in terms of public capital stacks rather than just private rounds, and investors are testing how to price businesses whose core markets may not fully mature for years. Founders in this space should watch Pasqal’s progress closely as they plan their own funding strategies and decide when, and how, to engage with public-market investors.